703
Views
10
CrossRef citations to date
0
Altmetric
Review

Antiviral therapies for managing viral hepatitis in lymphoma patients

, , &
Pages 363-376 | Received 05 Oct 2016, Accepted 26 Jan 2017, Published online: 15 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Michele Merli, Irene Defrancesco, Carlo Visco, Caroline Besson, Alice Di Rocco, Annalisa Arcari, Antonello Sica, Emanuele Cencini, Maria Chiara Tisi, Marco Frigeni, Paolo Grossi, Benedetta Bianchi, Barbara Mora, Lorenza Bertù, Raffaele Bruno, Francesco Passamonti & Luca Arcaini. (2020) Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphoma. Leukemia & Lymphoma 61:9, pages 2122-2128.
Read now
Stefano Molica, Luciano Levato, Rosanna Mirabelli, Alessanda Tedeschi & Mirella Lentini. (2018) Feasibility and safety of therapy with ibrutinib after antiviral control of hepatitis B virus (HBV) reactivation in chronic lymphocytic leukemia patients. Leukemia & Lymphoma 59:11, pages 2734-2736.
Read now

Articles from other publishers (8)

Patrice CacoubTarik Asselah. (2022) Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease. American Journal of Gastroenterology 117:2, pages 253-263.
Crossref
Xing Cao, Yafei Wang, Panyun Li, Wei Huang, Xiaojuan Lu & Hongda Lu. (2021) HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies. Frontiers in Oncology 11.
Crossref
William R. Treem, Melissa Palmer, Isabelle Lonjon-Domanec, Daniel Seekins, Lara Dimick-Santos, Mark I. Avigan, John F. Marcinak, Ajit Dash, Arie Regev, Eric Maller, Meenal Patwardhan, James H. Lewis, Don C. Rockey, Adrian M. Di Bisceglie, James W. Freston, Raul J. Andrade & Naga Chalasani. (2020) Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis. Drug Safety 44:2, pages 133-165.
Crossref
Michele Merli, Marco Frigeni, Laurent Alric, Carlo Visco, Caroline Besson, Lara Mannelli, Alice Di Rocco, Angela Ferrari, Lucia Farina, Mario Pirisi, Francesco Piazza, Véronique Loustaud-Ratti, Annalisa Arcari, Dario Marino, Antonello Sica, Maria Goldaniga, Chiara Rusconi, Massimo Gentile, Emanuele Cencini, Francesco Benanti, Maria Grazia Rumi, Virginia Valeria Ferretti, Paolo Grossi, Manuel Gotti, Roberta Sciarra, Maria Chiara Tisi, Isabel Cano, Valentina Zuccaro, Francesco Passamonti & Luca Arcaini. (2019) Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas. The Oncologist 24:8, pages e720-e729.
Crossref
Alfredo Marzano, Emanuele Angelucci, Marco Astegiano, Chiara Baratelli, Luigi Biancone, Paolo Bironzo, Giuseppina Brancaccio, Maurizia Rossana Brunetto, Raffaele Bruno, Patrizia Burra, Maria Giuseppina Cabras, Paolo Caraceni, Claudia Chialà, Maria Grazia Clemente, Agostino Colli, Bruno Daniele, Elisabetta De Gasperi, Vito Di Marco, Maria Chiara Ditto, Stefano Fagiuoli, Clodoveo Ferri, Giovanni Battista Gaeta, Paolo Antonio Grossi, Barbara Imperatrice, Pietro Lampertico, Fabio Salvatore Macaluso, Salvatore Madonia, Massimo Marignani, Chiara Mazzarelli, Alberto Mella, Gabriele Missale, Simone Parisi, Luisa Pasulo, Massimo Puoti, Maria Rendina, Davide Ribaldone, Giuseppe Rossi, Pierluigi Toniutto, Alessandra Tucci, Pietro Vajro, Mauro Viganò, Riccardo Volpes & Anna Linda Zignego. (2019) AISF position paper on HCV in immunocompromised patients. Digestive and Liver Disease 51:1, pages 10-23.
Crossref
Ya-fei Guo, Jing-xin Pan & Wei-huang Zhuang. (2018) Concurrent and reactivation of hepatitis B virus infection in diffuse large B-cell lymphoma: risk factors and survival outcome. Infectious Agents and Cancer 13:1.
Crossref
Lionel Piroth, Odile Launay, Patrick Miailhes, Fabrice Carrat & David Rey. (2018) Patients With Isolated Hepatitis B Core Antibody: Has the Time Come to Vaccinate?. Clinical Infectious Diseases 66:2, pages 317-318.
Crossref
Zilin Tang, Xiaodong Li, Shunquan Wu, Yan Liu, Yan Qiao, Dongping Xu & Jin Li. (2017) Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis. Hepatology International 11:5, pages 429-433.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.